Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Tullius

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 10, 2012
Vascularized composite allotransplantation research: the emerging fieldB Pomahac, Y T Becker, L Cendales, et al.
Kidney International|February 1, 2007
Donor age intensifies the early immune response after transplantationA Reutzel-Selke, A Jurisch, C Denecke, et al.
Transplantation Proceedings|March 27, 2001
Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1S G Tullius, M Nieminen-Kelhä, A Reutzel-Selke, et al.
Transplantation Proceedings|March 27, 2001
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allograftsS G Tullius, M Nieminen-Kelhä, U Bachmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 7, 2014
The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplantA Chandraker, R Arscott, G F Murphy, et al.
Transplantation Proceedings|September 2, 1998
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantationS Jonas, O Guckelberger, W O Bechstein, et al.
Transplantation Proceedings|March 27, 2001
Donor pretreatment of grafts from marginal donors improves long-term graft outcomeA Reutzel-Selke, S G Tullius, T Zschockelt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Improved long-term graft survival after HO-1 induction in brain-dead donorsK Kotsch, M Francuski, A Pascher, et al.
Transplantation|October 9, 1999
Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonistC Braun, T Conzelmann, S Vetter, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 10, 2012
Vascularized composite allotransplantation research: the emerging fieldB Pomahac, Y T Becker, L Cendales, et al.
Kidney International|February 1, 2007
Donor age intensifies the early immune response after transplantationA Reutzel-Selke, A Jurisch, C Denecke, et al.
Transplantation Proceedings|March 27, 2001
Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1S G Tullius, M Nieminen-Kelhä, A Reutzel-Selke, et al.
Transplantation Proceedings|March 27, 2001
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allograftsS G Tullius, M Nieminen-Kelhä, U Bachmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 7, 2014
The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplantA Chandraker, R Arscott, G F Murphy, et al.
Transplantation Proceedings|September 2, 1998
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantationS Jonas, O Guckelberger, W O Bechstein, et al.
Transplantation Proceedings|March 27, 2001
Donor pretreatment of grafts from marginal donors improves long-term graft outcomeA Reutzel-Selke, S G Tullius, T Zschockelt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2006
Improved long-term graft survival after HO-1 induction in brain-dead donorsK Kotsch, M Francuski, A Pascher, et al.
Transplantation|October 9, 1999
Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonistC Braun, T Conzelmann, S Vetter, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Pageof 11